Carcinogenesis, Vol. 21, No. 3, 485-495,
March 2000
© 2000 Oxford University Press
Cancer Biology |
Apoptosis in cancer
Cold Spring Harbor Laboratory, 1 Bungtown Road, PO Box 100, Cold Spring Harbor, New York, NY 11724, USA
In the last decade, basic cancer research has produced remarkable advances in our understanding of cancer biology and cancer genetics. Among the most important of these advances is the realization that apoptosis and the genes that control it have a profound effect on the malignant phenotype. For example, it is now clear that some oncogenic mutations disrupt apoptosis, leading to tumor initiation, progression or metastasis. Conversely, compelling evidence indicates that other oncogenic changes promote apoptosis, thereby producing selective pressure to override apoptosis during multistage carcinogenesis. Finally, it is now well documented that most cytotoxic anticancer agents induce apoptosis, raising the intriguing possibility that defects in apoptotic programs contribute to treatment failure. Because the same mutations that suppress apoptosis during tumor development also reduce treatment sensitivity, apoptosis provides a conceptual framework to link cancer genetics with cancer therapy. An intense research effort is uncovering the underlying mechanisms of apoptosis such that, in the next decade, one envisions that this information will produce new strategies to exploit apoptosis for therapeutic benefit.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Shkreta, U. Froehlich, E. R. Paquet, J. Toutant, S. A. Elela, and B. Chabot Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes Mol. Cancer Ther., June 1, 2008; 7(6): 1398 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Angell A study into the potential role of Survivin localization in resistance to drug-induced apoptosis Bioscience Horizons, June 1, 2008; 1(2): 85 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, A. T. C. Lee, J. Z. I. Ma, J. Wang, J. Ren, Y. Yang, E. Tantoso, K.-B. Li, L. L. P. J Ooi, P. Tan, et al. Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target J. Biol. Chem., May 9, 2008; 283(19): 13205 - 13215. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fromigue, Z. Hamidouche, and P. J. Marie Statin-Induced Inhibition of 3-Hydroxy-3-Methyl Glutaryl Coenzyme A Reductase Sensitizes Human Osteosarcoma Cells to Anticancer Drugs J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 595 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mazroui, S. Di Marco, E. Clair, C. von Roretz, S. A. Tenenbaum, J. D. Keene, M. Saleh, and I.-E. Gallouzi Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis J. Cell Biol., January 10, 2008; 180(1): 113 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, Z.-G. Lu, Y. Miki, and K. Yoshida Protein Kinase C {delta} Induces Transcription of the TP53 Tumor Suppressor Gene by Controlling Death-Promoting Factor Btf in the Apoptotic Response to DNA Damage Mol. Cell. Biol., December 15, 2007; 27(24): 8480 - 8491. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Drakos, A. Thomaides, L. J. Medeiros, J. Li, V. Leventaki, M. Konopleva, M. Andreeff, and G. Z. Rassidakis Inhibition of p53-Murine Double Minute 2 Interaction by Nutlin-3A Stabilizes p53 and Induces Cell Cycle Arrest and Apoptosis in Hodgkin Lymphoma Clin. Cancer Res., June 1, 2007; 13(11): 3380 - 3387. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, T. Sun, L. Xue, X. Han, B. Zhang, N. Lu, Y. Shi, W. Tan, Y. Zhou, D. Zhao, et al. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer Carcinogenesis, May 1, 2007; 28(5): 1067 - 1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Manjarrez, R. Ocadiz, L. Valle, C. Pacheco, A. Marroquin, C. De la Torre, M. Selman, and P. Gariglio Detection of Human Papillomavirus and Relevant Tumor Suppressors and Oncoproteins in Laryngeal Tumors Clin. Cancer Res., December 1, 2006; 12(23): 6946 - 6951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Fikaris, A. E. Lewis, A. Abulaiti, O. M. Tsygankova, and J. L. Meinkoth Ras Triggers Ataxia-telangiectasia-mutated and Rad-3-related Activation and Apoptosis through Sustained Mitogenic Signaling J. Biol. Chem., November 17, 2006; 281(46): 34759 - 34767. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tomiyama, S. Serizawa, K. Tachibana, K. Sakurada, H. Samejima, Y. Kuchino, and C. Kitanaka Critical role for mitochondrial oxidative phosphorylation in the activation of tumor suppressors bax and bak. J Natl Cancer Inst, October 18, 2006; 98(20): 1462 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Chin and R. Herbst Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint. Mol. Cancer Ther., October 1, 2006; 5(10): 2580 - 2591. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Veluri, R. P. Singh, Z. Liu, J. A. Thompson, R. Agarwal, and C. Agarwal Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells Carcinogenesis, July 1, 2006; 27(7): 1445 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Yun, M.-H. Kweon, H. Kwon, J.-K. Hwang, and H. Mukhtar Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145 Carcinogenesis, July 1, 2006; 27(7): 1454 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Park, J. M. Park, J. S. Jang, J. E. Choi, K. M. Kim, S. I. Cha, C. H. Kim, Y. M. Kang, W. K. Lee, S. Kam, et al. Caspase 9 promoter polymorphisms and risk of primary lung cancer Hum. Mol. Genet., June 15, 2006; 15(12): 1963 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Humphries, K. H. Limesand, J. C. Schneider, K. I. Nakayama, S. M. Anderson, and M. E. Reyland Suppression of Apoptosis in the Protein Kinase C{delta} Null Mouse in Vivo J. Biol. Chem., April 7, 2006; 281(14): 9728 - 9737. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Dharap, P. Chandna, Y. Wang, J. J. Khandare, B. Qiu, S. Stein, and T. Minko Molecular Targeting of BCL2 and BCLXL Proteins by Synthetic BCL2 Homology 3 Domain Peptide Enhances the Efficacy of Chemotherapy J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 992 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Schafer, A. B. Parrish, K. M. Wright, S. S. Margolis, J. R. Marks, M. Deshmukh, and S. Kornbluth Enhanced Sensitivity to Cytochrome c-Induced Apoptosis Mediated by PHAPI in Breast Cancer Cells Cancer Res., February 15, 2006; 66(4): 2210 - 2218. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Belkhiri, A. Zaika, N. Pidkovka, S. Knuutila, C. Moskaluk, and W. El-Rifai Darpp-32: a Novel Antiapoptotic Gene in Upper Gastrointestinal Carcinomas Cancer Res., August 1, 2005; 65(15): 6583 - 6592. [Abstract] [Full Text] [PDF] |
||||
![]() |
X Zhang, X Miao, T Sun, W Tan, S Qu, P Xiong, Y Zhou, and D Lin Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer J. Med. Genet., June 1, 2005; 42(6): 479 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Ghobrial, T. E. Witzig, and A. A. Adjei Targeting Apoptosis Pathways in Cancer Therapy CA Cancer J Clin, May 1, 2005; 55(3): 178 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cozzolino, P. Palladino, F. Rossi, G. Cali, E. Benedetti, and P. Laccetti Antineoplastic cyclic astin analogues kill tumour cells via caspase-mediated induction of apoptosis Carcinogenesis, April 1, 2005; 26(4): 733 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Yim, R. P. Singh, C. Agarwal, S. Lee, H. Chi, and R. Agarwal A Novel Anticancer Agent, Decursin, Induces G1 Arrest and Apoptosis in Human Prostate Carcinoma Cells Cancer Res., February 1, 2005; 65(3): 1035 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, M. Cuddy, T. Samuel, K. Welsh, A. Schimmer, F. Hanaii, R. Houghten, C. Pinilla, and J. C. Reed Cellular, Biochemical, and Genetic Analysis of Mechanism of Small Molecule IAP Inhibitors J. Biol. Chem., November 12, 2004; 279(46): 48168 - 48176. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kondoh, I. Suzuki, M. Sato, F. Nagashima, S. Simizu, M. Harada, M. Fujii, H. Osada, Y. Asakawa, and Y. Watanabe Kaurene Diterpene Induces Apoptosis in Human Leukemia Cells Partly through a Caspase-8-Dependent Pathway J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 115 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tyagi, C. Agarwal, G. Harrison, L. M. Glode, and R. Agarwal Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages Carcinogenesis, September 1, 2004; 25(9): 1711 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Trompier, X.-B. Chang, R. Barattin, A. d. M. d'Hardemare, A. Di Pietro, and H. Baubichon-Cortay Verapamil and Its Derivative Trigger Apoptosis through Glutathione Extrusion by Multidrug Resistance Protein MRP1 Cancer Res., July 15, 2004; 64(14): 4950 - 4956. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sun, X. Miao, X. Zhang, W. Tan, P. Xiong, and D. Lin Polymorphisms of Death Pathway Genes FAS and FASL in Esophageal Squamous-Cell Carcinoma J Natl Cancer Inst, July 7, 2004; 96(13): 1030 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Lin, C.-C. Chang, S.-T. Chen, H.-L. Chang, J.-L. Su, Y.-P. Chau, and M.-L. Kuo Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation J. Biol. Chem., June 4, 2004; 279(23): 24015 - 24023. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Staalesen, B. Leirvaag, J. R. Lillehaug, and P. E. Lonning Genetic and Epigenetic Changes in p21 and p21B Do Not Correlate with Resistance to Doxorubicin or Mitomycin and 5-Fluorouracil in Locally Advanced Breast Cancer Clin. Cancer Res., May 15, 2004; 10(10): 3438 - 3443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Karlsson, I. Ora, I. Porn-Ares, and S. Pahlman Arsenic Trioxide-Induced Death of Neuroblastoma Cells Involves Activation of Bax and Does Not Require p53 Clin. Cancer Res., May 1, 2004; 10(9): 3179 - 3188. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Albright, R. I. Salganik, and T. Van Dyke Dietary Depletion of Vitamin E and Vitamin A Inhibits Mammary Tumor Growth and Metastasis in Transgenic Mice J. Nutr., May 1, 2004; 134(5): 1139 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Han, M.-Y. Lee, K. D. Shin, S. B. Jeon, J. M. Kim, K.-H. Son, H.-C. Kim, H.-M. Kim, and B.-M. Kwon 2'-Benzoyloxycinnamaldehyde Induces Apoptosis in Human Carcinoma via Reactive Oxygen Species J. Biol. Chem., February 20, 2004; 279(8): 6911 - 6920. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fulda and K.-M. Debatin Sensitization for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis by the Chemopreventive Agent Resveratrol Cancer Res., January 1, 2004; 64(1): 337 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Singh, G. Sharma, G. U. Mallikarjuna, S. Dhanalakshmi, C. Agarwal, and R. Agarwal In Vivo Suppression of Hormone-Refractory Prostate Cancer Growth by Inositol Hexaphosphate: Induction of Insulin-Like Growth Factor Binding Protein-3 and Inhibition of Vascular Endothelial Growth Factor Clin. Cancer Res., January 1, 2004; 10(1): 244 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pingoud-Meier, D. Lang, A. J. Janss, L. B. Rorke, P. C. Phillips, T. Shalaby, and M. A. Grotzer Loss of Caspase-8 Protein Expression Correlates with Unfavorable Survival Outcome in Childhood Medulloblastoma Clin. Cancer Res., December 15, 2003; 9(17): 6401 - 6409. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Allal, L. Waelchli, and M.-A. Brundler Prognostic Value of Apoptosis-Regulating Protein Expression in Anal Squamous Cell Carcinoma Clin. Cancer Res., December 15, 2003; 9(17): 6489 - 6496. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Nguewa, M. A. Fuertes, C. Alonso, and J. M. Perez Pharmacological Modulation of Poly(ADP-ribose) Polymerase-Mediated Cell Death: Exploitation in Cancer Chemotherapy Mol. Pharmacol., November 1, 2003; 64(5): 1007 - 1014. [Full Text] [PDF] |
||||
![]() |
A. Ortega, P. Ferrer, J. Carretero, E. Obrador, M. Asensi, J. A. Pellicer, and J. M. Estrela Down-regulation of Glutathione and Bcl-2 Synthesis in Mouse B16 Melanoma Cells Avoids Their Survival during Interaction with the Vascular Endothelium J. Biol. Chem., October 10, 2003; 278(41): 39591 - 39599. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Vos, C. A. Ellis, C. Elam, A. S. Ulku, B. J. Taylor, and G. J. Clark RASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor J. Biol. Chem., July 18, 2003; 278(30): 28045 - 28051. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Misra, S. Ghatak, A. Zoltan-Jones, and B. P. Toole Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan J. Biol. Chem., July 3, 2003; 278(28): 25285 - 25288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Nguyen and J. A. Wells Direct activation of the apoptosis machinery as a mechanism to target cancer cells PNAS, June 24, 2003; 100(13): 7533 - 7538. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shimoda, W. E. Achanzar, W. Qu, T. Nagamine, H. Takagi, M. Mori, and M. P. Waalkes Metallothionein Is a Potential Negative Regulator of Apoptosis Toxicol. Sci., June 1, 2003; 73(2): 294 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Tidd, C. M. Broughton, and R. E. Clark CpG oligodeoxynucleotide 5mer-induced apoptosis in MOLT-4 leukaemia cells does not require caspase 3 or new protein synthesis Nucleic Acids Res., May 1, 2003; 31(9): 2297 - 2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Singh, C. Agarwal, and R. Agarwal Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes Carcinogenesis, March 1, 2003; 24(3): 555 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. M. Wo, L. Cai, Z. Zhou, D. Rosenbaum, C. Mendez, M. B. Ray, W. F. Jones, and Y. J. Kang Association of Metallothionein Expression and Lack of Apoptosis with Progression of Carcinogenesis in Barrett's Esophagus Experimental Biology and Medicine, March 1, 2003; 228(3): 286 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, T. Takasu, D. M. Perlman, M. S. Peterson, D. Burrichter, S. Avdulov, P. B. Bitterman, and V. A. Polunovsky Translation Factor eIF4E Rescues Cells from Myc-dependent Apoptosis by Inhibiting Cytochrome c Release J. Biol. Chem., January 24, 2003; 278(5): 3015 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Mercatante, J. L. Mohler, and R. Kole Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents J. Biol. Chem., December 13, 2002; 277(51): 49374 - 49382. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ansah and N. J. Gooderham The Popular Herbal Antimalarial, Extract of Cryptolepis sanguinolenta, Is Potently Cytotoxic Toxicol. Sci., December 1, 2002; 70(2): 245 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Agarwal, R. P. Singh, and R. Agarwal Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release Carcinogenesis, November 1, 2002; 23(11): 1869 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Tyagi, R. P. Singh, C. Agarwal, D. C. F. Chan, and R. Agarwal Silibinin Strongly Synergizes Human Prostate Carcinoma DU145 Cells to Doxorubicin-induced Growth Inhibition, G2-M Arrest, and Apoptosis Clin. Cancer Res., November 1, 2002; 8(11): 3512 - 3519. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Belhocine, N. Steinmetz, R. Hustinx, P. Bartsch, G. Jerusalem, L. Seidel, P. Rigo, and A. Green Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis Clin. Cancer Res., September 1, 2002; 8(9): 2766 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Ferreira, M. Epping, F. A. E. Kruyt, and G. Giaccone Apoptosis: Target of Cancer Therapy Clin. Cancer Res., July 1, 2002; 8(7): 2024 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, J. Li, L. E. Lantry, Y. Wang, R. W. Wiseman, R. A. Lubet, and M. You p53 Transgenic Mice Are Highly Susceptible to 1, 2-Dimethylhydrazine-induced Uterine Sarcomas Cancer Res., June 1, 2002; 62(11): 3024 - 3029. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-F. Cartron, L. Oliver, S. Martin, C. Moreau, M.-T. LeCabellec, P. Jezequel, K. Meflah, and F. M. Vallette The expression of a new variant of the pro-apoptotic molecule Bax, Bax{psi}, is correlated with an increased survival of glioblastoma multiforme patients Hum. Mol. Genet., March 1, 2002; 11(6): 675 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Singh, A. K. Tyagi, J. Zhao, and R. Agarwal Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis Carcinogenesis, March 1, 2002; 23(3): 499 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shureiqi, W. Jiang, S. M. Fischer, X. Xu, D. Chen, J. J. Lee, R. Lotan, and S. M. Lippman GATA-6 Transcriptional Regulation of 15-Lipoxygenase-1 during NSAID-induced Apoptosis in Colorectal Cancer Cells Cancer Res., February 1, 2002; 62(4): 1178 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippman and W. Ki Hong Cancer Prevention by Delay : Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002. Clin. Cancer Res., February 1, 2002; 8(2): 305 - 313. [Full Text] |


















